Literature DB >> 1324914

Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.

N Goode1, K Hughes, J R Woodgett, P J Parker.   

Abstract

In cells, stimulation of protein kinase C (PKC) results in the dephosphorylation of specific residues proximal to the DNA binding domain of c-Jun, a major component of the AP-1 transcription factor. Since phosphorylation of this region of c-Jun inhibits interaction with DNA, this pathway may contribute to PKC activation of AP-1. To determine the mechanism(s) underlying this pathway, possible interactions between PKC and proteins implicated in c-Jun regulation are being investigated. Here it is shown that glycogen synthase kinase-3 beta (GSK-3 beta), a serine/threonine kinase that specifically targets the inhibitory c-Jun phosphorylation sites, is phosphorylated in vitro by particular forms of PKC (alpha, beta 1, gamma greater than beta 2; not epsilon). By contrast, the related GSK-3 alpha is not a substrate for any of these PKC isotypes. Phosphorylation of GSK-3 beta by PKC results in its specific inactivation. These results are consistent with a model in which activation of PKC stimulates c-Jun DNA binding by inhibiting its phosphorylation by GSK-3 beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  122 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  Integrin regulation of beta-catenin signaling in ovarian carcinoma.

Authors:  Rebecca J Burkhalter; Jaime Symowicz; Laurie G Hudson; Cara J Gottardi; M Sharon Stack
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

Review 4.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

5.  Differing semaphorin 3A concentrations trigger distinct signaling mechanisms in growth cone collapse.

Authors:  Richard P C Manns; Geoffrey M W Cook; Christine E Holt; Roger J Keynes
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

6.  Time-varying causal inference from phosphoproteomic measurements in macrophage cells.

Authors:  Maryam Masnadi-Shirazi; Mano Ram Maurya; Shankar Subramaniam
Journal:  IEEE Trans Biomed Circuits Syst       Date:  2014-02       Impact factor: 3.833

Review 7.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

8.  Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.

Authors:  A Mudher; S Chapman; J Richardson; A Asuni; G Gibb; C Pollard; R Killick; T Iqbal; L Raymond; I Varndell; P Sheppard; A Makoff; E Gower; P E Soden; P Lewis; M Murphy; T E Golde; H T Rupniak; B H Anderton; S Lovestone
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

9.  Expression of mammalian protein kinase C in Schizosaccharomyces pombe: isotype-specific induction of growth arrest, vesicle formation, and endocytosis.

Authors:  N T Goode; M A Hajibagheri; G Warren; P J Parker
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

10.  Protein kinase C betaII and PKCiota/lambda: collaborating partners in colon cancer promotion and progression.

Authors:  Nicole R Murray; Justin Weems; Ursula Braun; Michael Leitges; Alan P Fields
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.